4Walker RH, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med. 1989,113(3): 254.
5Geifman-Holtzman O, Wojtowycz M, Kosmas E, et al. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol, 1997,89(2) :272.
6Serrano J. Incidence and characterization of erythrocyte antibodies in a hospital blood bank. Study over a period of 9 years (1980-1988) Sangre (Barc), 1990,35(5):363.
7Romphruk AV, Wanhagij C, Akahat J. Anti-P1: the most common unexpected antibodies in northeastern-Thais. J Med Assoc Thai,1999, 82(8) :803.
8Lin M. Blood groups and transfusion medicine in Taiwan. J Formos Med Assoc, 1997, 96(12):933.
9Winters JL, Pineda AA, Gorden LD, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota.Transfusion, 2001,41(11): 1413.
10Hundric-Haspl Z, Jurakovic-Loncar N, Grgicevic D, et al. Alloimmunizations following blood transfusions. Acta Med Croatica, 1994,48(4-5): 193-7Related Articles.
5Makarovska-Bojadzieva T, Blagoevska M,Kolevski P, et al. Optimal blood grouping and antibody screening for safe transfusion[J]. Prilozi,2009,30(1):119-128.
6Noizat-Pirenne F,Tournamille C. Relevance of RH variants in transfusion of sickle cell patients [J]. Transfusion Clinique et Biologique , 2011, (18) : 527-533.
7WM Birgid Neumeister . Recent and future trends in blood group typing [J], Anal Bioanal Chem, 2009,393: 1443-1451.
8Pathak S,Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank : Is AHG crossmatch still required? A study at a multispecialty corporate hospital in India [J]. Asian J Transfus Sci, 2011, 5(2):153-156.
